文献速递冠心病

稳定性冠心病PCI后FFR与生活质量改善的关系

Fractional Flow Reserve and Quality-of-Life Improvement After Percutaneous Coronary Intervention in Patients With Stable Coronary Artery Disease.
PubMed 文献 · Circulation · 2018-01-01

该研究基于FAME 1和2试验,纳入706例至少一处FFR≤0.80并接受PCI的稳定性冠心病患者,以及185例无FFR≤0.80病灶的药物治疗患者作为参照。采用EQ-5D指数评估基线、1个月和1年生活质量,发现各异常FFR三分位组PCI后生活质量均显著改善,参照组无变化;FFR越低、ΔFFR越大、心绞痛分级越高,生活质量改善幅度越大。

要点

  • 稳定性冠心病患者PCI后生活质量改善程度与FFR值相关,FFR越低改善越明显。
  • ΔFFR越大及心绞痛分级越高,PCI后1个月和1年生活质量改善幅度越大。
  • 无FFR≤0.80病灶的药物治疗患者生活质量未见显著变化。

核心结论

  • 在稳定性冠心病患者中,FFR和心绞痛严重程度可预测PCI后生活质量的改善。

研究设计与样本

  • 基于FAME 1和2试验,纳入706例至少一处FFR≤0.80并接受PCI的稳定性冠心病患者,及185例无FFR≤0.80病灶的药物治疗参照组。
  • 采用欧洲五维健康量表(EQ-5D)指数在基线、1个月和1年评估生活质量。

主要发现

  • 各异常FFR三分位组PCI后生活质量均显著改善,而参照组无变化。
  • 最低异常FFR亚组在1个月时生活质量改善最大(P<0.001)。
  • 混合效应模型中,较低FFR(1个月P=0.002,1年P=0.049)、较大ΔFFR(1个月P=0.021,1年P=0.025)和较高心绞痛分级(1个月P=0.001,1年P<0.001)与1个月和1年生活质量改善幅度最大相关。

临床怎么用

  • 对于稳定性冠心病患者,FFR值越低、ΔFFR越大及心绞痛分级越高,PCI后生活质量改善可能越明显。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Whether the benefit in quality of life (QOL) after percutaneous coronary intervention depends on the severity of the stenosis as determined by fractional flow reserve (FFR) remains unknown. This study sought to investigate the relationship between FFR values and improvement in QOL. METHODS: From the FAME 1 and 2 trials (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation), we identified 706 stable patients with coronary artery disease who had at least 1 lesion with an FFR≤0.80 that was treated with percutaneous coronary intervention and 185 patients with coronary artery disease who had no lesion with an FFR≤0.80 and were treated medically who served as a reference group. QOL was assessed by the European Quality of Life-5 Dimensions index at baseline, 1 month, and 1 year. We assessed the relationship between QOL improvement (defined as the change in European Quality of Life-5 Dimensions index from baseline) and FFR as a continuous value and according to abnormal FFR tertile. RESULTS: QOL improved significantly after percutaneous coronary intervention in each abnormal FFR tertile, whereas it did not change in the reference group. The lowest abnormal FFR subgroup had the greatest improvement in QOL at 1 month ( P<0.001). In mixed-effects models for repeated measures, lower FFR ( P=0.002 for 1 month and 0.049 for 1 year), greater delta FFR ( P=0.021 for 1 month and 0.025 for 1 year), and higher angina class ( P=0.001 for 1 month and <0.001 for 1 year) were associated with the greatest magnitude of QOL improvement at both 1 month and 1 year. CONCLUSIONS: Among patients with stable coronary artery disease, FFR and angina severity predict QOL improvement after percutaneous coronary intervention. CLINICAL TRIAL REGISTRATION: URL: https://www.clinicaltrials.gov . Unique identifiers: NCT00267774 and NCT01132495.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Nishi T, Piroth Z, De Bruyne B, et al. Fractional Flow Reserve and Quality-of-Life Improvement After Percutaneous Coronary Intervention in Patients With Stable Coronary Artery Disease. Circulation. 2018. PMID: 30354650. doi:10.1161/CIRCULATIONAHA.118.035263

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。